Skip to content

Clinical trial to evaluate the safety, efficacy, and economic feasibility of virtual reality-based ‘Emotion to Emotion Therapy’ for post-traumatic stress disorder patients

Clinical trial to evaluate the safety, efficacy, and economic feasibility of virtual reality-based ‘Emotion to Emotion Therapy’ for post-traumatic stress disorder patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007845
Enrollment
72
Registered
2022-10-25
Start date
2022-11-30
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Emotion to Emotion Therapy/ Virtual reality-based ‘Emotion to Emotion Therapy’) : ? Experimental 1: VR-based 'Emotion to Emotion Therapy(ETE therapy)' Group - Twice a week 16 times for 8 weeks,

Sponsors

Wonkwang University Sanbon Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adult men and women aged 18 to 65 2) Those diagnosed with post-traumatic stress disorder by the Structured Clinical Interview for DSM-5(SCID-5) 3) PC-PTSD-5 score of 3 or higher 4) A person who voluntarily decided to participate and signed the consent form

Exclusion criteria

Exclusion criteria: 1) People with highly psychiatric disorders ? If you have delusions or hallucinations based on a recent or past medical history ? At least one episode of mania ? If you have a history of alcohol abuse or dependence ? Those at risk of suicide 2) In case of continuous administration of substances that are judged to affect symptom induction except for concomitant drugs 3) Those with congenital diseases, central nervous system, peripheral nervous system disease, endocrine system disease, immunological disease, heart, liver, or kidney problems 4) Those who are pregnant or lactating 5) Those who have participated in other clinical studies in the past month or are currently participating in other clinical studies 6) Those in charge of clinical trials or those in charge of clinical trials who are judged to be difficult to conduct other clinical trials

Design outcomes

Primary

MeasureTime frame
Korean version of PTSD Checklist-5

Secondary

MeasureTime frame
The Clinical Global Impression – Improvement scale;Korean version of Posttraumatic Growth Inventory;Five Facet Mindfulness Questionnaire Short Form;Patient Health Questionnaire-15;Hospital Anxiety and Depression Scale;Korean version of Insomnia severity index;Hwa-Byung Scale;EuroQoL-5 Dimension;EuroQoL-Visual analogue scale;cost assessment;Mentalizing the Rooms of Mind;The Core Seven-Emotions Inventory Short Form;Subjective Units of Disturbance Scale;Heart Rate Variation;Quantative Encephalogram

Countries

Korea, Republic of

Contacts

Public ContactDoeun Lee

Wonkwang University

dolee0210@gmail.com+82-31-390-2763

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Sep 4, 2026